Authors: Dalal Arman, Karthikeswari Karthikeswari, Adhikary Krishnendu, Aleemuddin Mohammad, Wasnik Smita Pandharinath, Bharti Rahul, Kaladhar Dowluru S.V.G.K, Gupta Sandeep, Dudhe Prashik Bhimrao, Dudhe Sujata Prashik
Authors: Md Sajid Ali, Rajendra Dnyandeo Dighe, V. Antony Asir Daniel, Saloni Kakkar, Sampath A Gouru, Kausik Bhar, Ramesh R.Pagore, Ramesh R. Pagore, Arman Dalal
DOI: 10.13005/ojc/420109
Type 2 Diabetes Mellitus is an extensive metabolic disorder, and dipeptidyl peptidase-4 is an important target for therapeutic strategies (World Health Organization, 2021). This study uses in silico molecular docking to examine the potential of four flavonoids from Trigonella foenum-graecum (fenugreek) seeds: rutin, quercetin, vitexin, and isovitexin, as natural dipeptidyl peptidase-4 (DPP-4) inhibitors for antidiabetic action. AutoDock Vina was used to dock the chosen ligands with the DPP-4 enzyme (PDB ID: 2OQV) while minimizing their energy. The binding interactions were then examined. At important catalytic residues, rutin showed significant hydrogen bonding and hydrophobic interactions, outperforming the co-crystallized inhibitor with the greatest binding affinity (−9.4 kcal/mol). Rutin's molecular complementarity was found to be favorable when the interaction profiles and binding orientations were examined using Discovery Studio Visualizer. According to the study, rutin's better binding affinity and interaction network suggest that it may have natural DPP-4 inhibitory properties. These findings offer valuable insights into fenugreek’s antidiabetic efficacy and support its traditional usage, suggesting further experimental validation of rutin for drug development.
Authors: Venkatesan Natarajan, Arman Dalal, Radhika Tippani, Abdul Ajeed Mohathasim Billah, Shoheb Shakil Shaikh, Suresh V. Chinni, Kiruba Mohandoss
This chapter overviews the new science of artificial gametes, ready to transform reproductive biology and biotechnology. Leveraging developments in nanotechnology, stem cell science, and genetic engineering, artificial gametes open up untold promise in the reversal of fertility, prenatal disease prevention, and reproductive inclusivity across a variety of population categories, including lesbian, gay, bisexual, transgender, and queer individuals and the infertile people. The chapter examines the molecular basis of gametogenesis, the integration of synthetic gametes into artificial wombs, and the future of xenogametes and post-species reproductive engineering. It also explores bioethical and legal concerns of synthetic gametes, including genetic manipulation, germline editing, and regulation of these technologies. The discussion also encompasses the potential impact of predictive models and digital twins on reproductive planning and how the creation of synthetic life beyond conventional biological standards has promised and presented challenges.
Authors: Dalal Arman, Angad Angad, Jadhav Rakesh Sahebrao, Chandrakar Bhumika, Karthikeswari Karthikeswari, Gupta Sandeep, Krishnaveni M, Dowluru Satya Venkata Rishna Kaladhar, Adhikary Krishnendu, Patil Aditya Dilipkumar
Herbal remedies have long been integral to traditional medicine, offering a rich source of compounds with therapeutic potential. This study presents a comprehensive approach to inflammation management, bridging the gap between traditional herbal practices and modern pharmacology. Through an exploration of diverse herbal remedies, we investigated their effectiveness in addressing inflammation, a pervasive condition implicated in various diseases. The herbs known for their anti-inflammatory properties, elucidating the underlying mechanisms through which they modulate inflammatory pathways. Additionally, we discuss the integration of these herbal remedies with contemporary pharmacological strategies to achieve a synergistic and comprehensive approach to inflammation management. The potential synergy between traditional herbal knowledge and modern scientific methodologies, emphasizing the importance of evidence-based practices. The safety, efficacy, and standardization are discussed to facilitate the integration of herbal remedies into mainstream medical approaches. The intersection between traditional herbal remedies and modern pharmacology presents a promising avenue for comprehensive inflammation management. This study undertakes a thorough exploration of diverse herbal compounds renowned for their anti-inflammatory properties, aiming to bridge the historical wisdom of traditional medicine with contemporary scientific understanding. Through a systematic review of the literature, we identify key herbs that have shown efficacy in modulating inflammatory pathways. The study delves into the intricate molecular mechanisms underpinning the anti-inflammatory effects of these herbs, shedding light on their potential synergies when integrated with modern pharmaceutical approaches.
Authors: Dalal Arman, Kaushik Dinesh, Jain Saroj
The present research work is aimed to formulate and evaluate Nitrendipine nanosuspension (NTD-NS) and nanosuspension loaded oral fast dissolving film (NS-OFDF) to improve its low solubility and bioavailability. Wet media milling technique was employed to prepare NTD-NS, which was optimized and evaluated for different parameters. Poloxamer 188, Poloxamer 407, HPC, HPMC E5, HPMC E15, HPMC E50, HPMC K4M, PVP K30 were used for preparing various nanosuspension formulations. HPMC E15 and SLS were used to formulate optimized nanosuspension. NTD-OFDF was prepared using the optimized nanosuspension by solvent casting method. PEG 400 is added during film formation as plasticizers and HPMC is added as film former polymer. The NTD-OFDF were prepared, optimized and evaluated for different parameters. Optimized NTD-NS depicted particle size of 455.2 nm with polydispersity index (PDI) of 24.9% and zeta potential of -24.2 mV. Optimized NTD-OFDF exhibited surface pH of 7.12±0.0251, folding endurance of321±4, thickness of 0.171±0.003, disintegration time of 28.133±0.493 sec which was in the standard limits. The drug release from NTD-NS loaded OFDFs increased significantly, reaching a maximum of 80.84±0.445 % in pH 7.4 buffer, the release data was fitted into first order model yielding the highest correlation coefficient (R2) (R2=0.925).
Authors: Gajanand Pujari, G. Neethirajan, Arman Dalal, Ramanlal Narayan Kachave, Anuradha Pannu, Shivam Suresh Lale, Arpan Kumar Tripathi, Dharna Thakur, Md Tausif Raza, Nikunj B. Patel, Mamta Tripathi
Parkinson’s disease (PD) is a neurodegenerative disorder that progressively deteriorates the nervous system. Its causes are multifaceted, involving environmental influences, genetic predispositions, and epigenetic modifications. The main and inciting symptoms of PD are a combination of motor (bradykinesia, rest tremor and rigidity) and non-motor (hallucinations, compulsive behaviours and sleep disorders) symptoms. The existing treatments are mainly composed of a combination of medications that focus on treating the symptoms of the disease by replacing the lost dopamine without identifying the cause of the disease. Although beneficial, these therapies display a concerning amount of heterogeneity in drug response. Pharmacogenetics, a part of pharmacogenomics, helps to highlight the genetic factors that contribute to such heterogeneity in drug response. In the treatment of patients with PD, pharmacogenetic studies are particularly important given the variability of results, primarily concerning levodopa and dopaminergic therapies. This review covers the genetic mutation related to PD genes such as LRRK2, SNCA, and PARK2, which will be taken into account concerning their effects on disease progression and drug response. Genetic polymorphisms can significantly modulate the efficacy and adverse effects of drugs in patients with PD, influencing drug metabolism, transport, and receptor binding, among others, and involve genes such as CYP2D6 and COMT. This would be achieved through the application of pharmacogenetic insights that allow for tailored therapy approaches, optimize dosages, reduce adverse effects, and ensure better patient outcomes. Personalized medicine in PD could potentially enable improvement in treatment strategies based on an individual's genetic profile and thereby enhance management for this complex disease.
Authors: Renu Tushir, Ajesh Chauhan, Ruchi Bansal, Arman Dalal, Pankaj Kumar
Clotrimazole is marketed as a regularly occurring drug under numerous distinct names and via means of numerous agencies because of its antifungal activity. Clotrimazole, an artificial imidazole derivative, is often used domestically for the remedy of vaginal and pores and skin infections because of yeasts and dermatophytes. It shows maximum activity towards Candida spp., Trichophyton spp., Microsporum spp. and Malazzesia furfur (Pityrosporon orbicular) in vitro. In addition, it also has a few in vitro towards Gram positive bacteria, and at very high concentrations shows activity towards Trichomonas spp. In the remedy of vaginal candidiasis, Clotrimazole vaginal pills have produced treatment costs similar with the ones of traditional nystatin vaginal pills. Clotrimazole has been a success in sufferers of non- responsive patients to different antifungal formulations together with nystatin and amphotericin B. Results in trichomonal vaginitis are not impressive. Skin infections because of Candida or dermatophytes had been successfully deals with topical use of clotrimazole. In comparative trials, clotrimazole cream has been as powerful as Whitfield's ointment and tolnaftate with inside the remedy of dermatophytosis , and as powerful as nystatin in cutaneous candidiasis. Clotrimazole topical formulations are well tolerated; however skin infection has withdrawal of remedy in some cases. Candida septicemia and urinary and pulmonary candidiasis had been cured with oral clotrimazole remedy. Results in different kinds of fungal infections, such as pulmonary aspergillosis, had been disappointing. A restricting issue in oral clotrimazole remedy is the excessive occurrence of gastro- intestinal disturbances and neurological reactions.
No matching articles
Try another word from the title, author or DOI.
